Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Cleveland JLF"'
Autor:
Doolin JW; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Haakenstad EK; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Neville BA; Center for Surgery and Public Health, Brigham and Womens' Hospital, Boston, MA., Lipsitz SR; Center for Surgery and Public Health, Brigham and Womens' Hospital, Boston, MA., Zhang S; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Cleveland JLF; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Hiruy S; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Hassett MJ; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Revette A; Department of Quality and Patient Safety, Dana-Farber Cancer Institute, Boston, MA., Schrag D; Memorial Sloan Kettering Cancer Center, New York, NY., Basch E; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill, NC., McCleary NJ; Department of Medical Oncology, Gastrointestinal Oncology, Dana-Farber Cancer Institute, Boston, MA.
Publikováno v:
JCO clinical cancer informatics [JCO Clin Cancer Inform] 2023 Sep; Vol. 7, pp. e2300043.
Autor:
McCleary NJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Haakenstad EK; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Cleveland JLF; Information & Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Manni M; Information & Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Hassett MJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Schrag D; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
JAMIA open [JAMIA Open] 2022 Jul 26; Vol. 5 (3), pp. ooac064. Date of Electronic Publication: 2022 Jul 26 (Print Publication: 2022).
Autor:
Garcia Farina E; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Rowell J; University of Virginia, Charlottesville., Revette A; Survey and Data Management Core, Dana-Farber Cancer Institute, Boston, Massachusetts., Haakenstad EK; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Cleveland JLF; Information & Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Allende R; Social Work, Dana-Farber Cancer Institute, Boston, Massachusetts., Hassett M; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Schrag D; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., McCleary NJ; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Jul 01; Vol. 5 (7), pp. e2223898. Date of Electronic Publication: 2022 Jul 01.
Autor:
Keating NL; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.; Division of General Internal Medicine, Brigham and Women's Hospital, Boston, Massachusetts., Cleveland JLF; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, Massachusetts., Wright AA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts., Brooks GA; Section of Medical Oncology, Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire., Meneades L; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts., Riedel L; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts., Zubizarreta JR; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Statistics, Harvard Faculty of Arts and Sciences, Cambridge, Massachusetts., Landrum MB; Department of Health Care Policy, Harvard Medical School, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2021 Mar 01; Vol. 4 (3), pp. e212474. Date of Electronic Publication: 2021 Mar 01.
Autor:
Kadish SS; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Mayer EL; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Jackman DM; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Pomerantz M; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Brady L; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Dimitriadis A; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Cleveland JLF; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA., Wagner AJ; Dana-Farber Cancer Institute, and Partners Healthcare, Boston, MA.
Publikováno v:
Journal of oncology practice [J Oncol Pract] 2018 Jul; Vol. 14 (7), pp. e421-e428. Date of Electronic Publication: 2018 Jun 25.